Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 3, 2009, Pages 459-467

  Shim, Ju Hyun ^a   Park, Joong Won ^a   Nam, Byung Ho ^a   Lee, Woo Jin ^a   Kim, Chang Min ^a  

^a National Cancer Center   (South Korea)

Author keywords

Capecitabine; Cisplatin; Hepatocellular carcinoma; Response; Survival; Time to progression

Indexed keywords

CAPECITABINE; CISPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HAND FOOT SYNDROME; HAZARD RATIO; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 58249125747     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0759-x     Document Type: Article

References (32)

1. P Pisani DM Parkin F Bray J Ferlay 1999 Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18 29 (Pubitemid 29409471)
2. Welfare MoHa (2003) 2002 Annual Report of the Korea Central Cancer Registry. In Edition Gyeonggi-do: National Cancer Center, Ministry of Health and Welfare
3. M Sherman 1999 Screening for hepatocellular carcinoma Baillieres Best Pract Res Clin Gastroenterol 13 623 635 (Pubitemid 30050463)
4. J Bruix M Sherman JM Llovet 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430
5. AS Befeler AM Di Bisceglie 2002 Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 1609 1619 (Pubitemid 34533556)
6. JM Llovet J Bruix GJ Gores 2000 Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy Hepatology 31 1019 1021 (Pubitemid 30169952)
7. CM Lo H Ngan WK Tso 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 (Pubitemid 34454013)
8. MA Avila C Berasain B Sangro J Prieto 2006 New therapies for hepatocellular carcinoma Oncogene 25 3866 3884 (Pubitemid 43980482)
9. S Louafi V Boige M Ducreux 2007 Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study Cancer 109 1384 1390 (Pubitemid 46466566)
10. V Boige JL Raoul JP Pignon 2007 Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial Br J Cancer 97 862 867 (Pubitemid 47519302)
11. Llovet J RS, Mazzaferro V et al (2007) Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebo-controlled trial (SHARP trial). J Clin Oncol (Meeting Abstracts) 25(18S):Abstract LBA1
12. G Falkson LM Ryan LA Johnson 1987 A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study Cancer 60 2141 2145 (Pubitemid 17153471)
13. YZ Patt MM Hassan A Aguayo 2004 Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma Cancer 101 578 586 (Pubitemid 38970609)
14. S von Delius C Lersch M Mayr 2007 Capecitabine for treatment of advanced hepatocellular carcinoma Hepatogastroenterology 54 2310 2314
15. SH Park Y Lee SH Han 2006 Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma BMC Cancer 6 3 (Pubitemid 43078827)
16. YS Hong J Lee SC Lee 2007 Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer Cancer Chemother Pharmacol 60 321 328 (Pubitemid 46944586)
17. TW Kim YK Kang JH Ahn 2002 Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer Ann Oncol 13 1893 1898 (Pubitemid 36049952)
18. J Zhou ZY Tang J Fan 2003 Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor Clin Cancer Res 9 6030 6037 (Pubitemid 38018090)
19. G Liu E Franssen MI Fitch E Warner 1997 Patient preferences for oral versus intravenous palliative chemotherapy J Clin Oncol 15 110 115 (Pubitemid 27021524)
20. JW Park 2004 Practice guideline for diagnosis and treatment of hepatocellular carcinoma Korean J Hepatol 10 88 98
21. S Ueno G Tanabe K Nuruki 2002 Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis Hepatol Res 24 395 403 (Pubitemid 36002129)
22. JW Park M An JI Choi 2007 Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a Hepatitis B virus-endemic area J Cancer Res Clin Oncol 133 937 943 (Pubitemid 47561709)
23. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
24. G Capuano B Daniele GB Gaeta 1998 A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators Hepatology 28 751 755
25. JH Cheon JW Park KW Park 2004 The clinical report of 1, 078 cases of hepatocellular carcinomas: National Cancer Center experience Korean J Hepatol 10 288 297
26. MB Thomas AX Zhu 2005 Hepatocellular carcinoma: the need for progress J Clin Oncol 23 2892 2899 (Pubitemid 46224106)
27. C Twelves R Glynne-Jones J Cassidy 1999 Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites Clin Cancer Res 5 1696 1702 (Pubitemid 29334448)
28. M Ikeda T Okusaka H Ueno 2005 A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma Cancer 103 756 762 (Pubitemid 40216404)
29. J Lee JO Park WS Kim 2004 Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma Cancer Chemother Pharmacol 54 385 390 (Pubitemid 39462962)
30. TW Leung YZ Patt WY Lau 1999 Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma Clin Cancer Res 5 1676 1681 (Pubitemid 29334445)
31. KW Park JW Park JI Choi 2007 Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area J Gastroenterol 23 467 473
32. PM Schmidt 1983 Hematologic anomalies in alcoholic cirrhosis Schweiz Med Wochenschr 113 1025 1030